COMMUNIQUÉS West-GlobeNewswire

BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
27/08/2025
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases [...]
Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025
27/08/2025
Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 Halle (Saale) / Munich, Germany, August 27 , 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; [...]
Idorsia successfully completes convertible bonds restructuring
27/08/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 27, 2025 Idorsia Ltd (SIX: IDIA) settled the repurchase offer for its outstanding CHF 204 * million convertible bonds maturing in 2025 ( CB 2025 [...]

Pages